Repurposed bunamidine disrupts envelope energetics and induces ROS-mediated non-lytic killing
Open Access
- 4 February 2026
- journal article
- research article
- Published by Springer Nature in AMB Express
- Vol. 16 (1)
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) remains a major public health threat due to its multidrug resistance, biofilm formation, and persistence, which collectively limit the effectiveness of current antibiotics. Here we characterize bunamidine hydrochloride (BUN), a repurposed benzimidazole derivative, as a potent anti-MRSA candidate. Across clinical and reference isolates, BUN displayed low MIC/MBC values (4–8 μg/mL), rapid bactericidal activity, and consistent efficacy in both planktonic and biofilm-associated populations. BUN eradicated persister cells within hours, while exhibiting a markedly reduced propensity for resistance development compared with ciprofloxacin. Mechanistic analyses revealed that BUN disrupts envelope energetics—causing membrane depolarization, collapse of the proton motive force, ATP depletion, and lipid disorder—without pore formation. These events triggered amplification of reactive oxygen species (ROS), which acted as critical execution factors for bacterial killing. Hemolysis assays confirmed selective compatibility with mammalian membranes, consistent with a non-lytic mode of action. In murine abscess and wound infection models, which represent early acute infection stages rather than established biofilm or chronic conditions, topical BUN treatment reduced bacterial burden, accelerated wound closure, and alleviated inflammation without apparent toxicity. These results demonstrate early therapeutic efficacy, tissue-protective, and anti-inflammatory effects in acute infection settings. While the current in vivo models support antibacterial efficacy during early infection, evaluation in established biofilm or chronic infection models will be an important direction for future studies.Keywords
Funding Information
- Changsha Science and Technology Project (kq2403195)
- Science and Technology Program of Hunan Province (2024JJ6081)
This publication has 51 references indexed in Scilit:
- Novel antibiotics against Staphylococcus aureus without detectable resistance by targeting proton motive force and FtsHMedcomm, 2025
- Antimicrobial polymer-loaded hydrogels for the topical treatment of multidrug-resistant wound biofilm infectionsJournal of Controlled Release, 2023
- L007-0069 kills Staphylococcus aureus in high resistant phenotypesCellular and Molecular Life Sciences, 2022
- Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSAApplied Microbiology and Biotechnology, 2022
- Bacterial Metabolism and Antibiotic EfficacyCell Metabolism, 2019
- Reactive oxygen: A novel antimicrobial mechanism for targeting biofilm-associated infectionJournal of Global Antimicrobial Resistance, 2017
- Hemolytic Activity of Antimicrobial Peptides2016
- Molecular mechanisms of membrane targeting antibioticsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2016
- Comparison of multiple methods for quantification of microbial biofilms grown in microtiter platesJournal of Microbiological Methods, 2008
- MyD88 Mediates Neutrophil Recruitment Initiated by IL-1R but Not TLR2 Activation in Immunity against Staphylococcus aureusImmunity, 2006